Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.11 USD | +1.59% | -13.28% | +7.02% |
14/05 | Aprea Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02/05 | Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza as Chief Medical Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.02% | 2.73Cr | |
+63.49% | 6.26TCr | |
-1.24% | 4.12TCr | |
+44.76% | 4.03TCr | |
-8.29% | 2.79TCr | |
+13.00% | 2.62TCr | |
-21.66% | 1.91TCr | |
+5.37% | 1.31TCr | |
+25.53% | 1.23TCr | |
+28.41% | 1.21TCr |
- Stock Market
- Equities
- APRE Stock
- News Aprea Therapeutics, Inc.
- Sector Update: Health Care Stocks Mixed In Premarket Trading